STAT+: Pharmalittle: Study of Covid-19 therapy revives debate over FDA clearance; pharma companies are ready to make deals
A new class of treatments for Covid-19 variants could help restock the country’s armory but faces an uncertain road to the commercial market.
Top of the morning to you, and a fine one it is. Although gray skies are hovering over the Pharmalot campus, our spirits
